78 related articles for article (PubMed ID: 20332439)
1. Expression and role of phosphodiesterase 5 in human malignant melanoma cell line.
Murata T; Shimizu K; Watanabe Y; Morita H; Sekida M; Tagawa T
Anticancer Res; 2010 Feb; 30(2):355-8. PubMed ID: 20332439
[TBL] [Abstract][Full Text] [Related]
2. Characterization of phosphodiesterase 1 in human malignant melanoma cell lines.
Shimizu K; Murata T; Watanabe Y; Sato C; Morita H; Tagawa T
Anticancer Res; 2009 Apr; 29(4):1119-22. PubMed ID: 19414353
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C
Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368
[TBL] [Abstract][Full Text] [Related]
4. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
5. A role for cyclic nucleotide phosphodiesterase 4 in regulation of the growth of human malignant melanoma cells.
Narita M; Murata T; Shimizu K; Nakagawa T; Sugiyama T; Inui M; Hiramoto K; Tagawa T
Oncol Rep; 2007 May; 17(5):1133-9. PubMed ID: 17390056
[TBL] [Abstract][Full Text] [Related]
6. Isolation of two isoforms of phosphodiesterase 5 from rat penis.
Lin CS; Lin G; Lue TF
Int J Impot Res; 2003 Apr; 15(2):129-36. PubMed ID: 12789393
[TBL] [Abstract][Full Text] [Related]
7. Characterization of phosphodiesterase 3 in human malignant melanoma cell line.
Murata T; Shimizu K; Narita M; Manganiello VC; Tagawa T
Anticancer Res; 2002; 22(6A):3171-4. PubMed ID: 12530061
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1.
Abusnina A; Keravis T; Yougbaré I; Bronner C; Lugnier C
Mol Nutr Food Res; 2011 Nov; 55(11):1677-89. PubMed ID: 22045655
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation.
Gantner F; Götz C; Gekeler V; Schudt C; Wendel A; Hatzelmann A
Br J Pharmacol; 1998 Mar; 123(6):1031-8. PubMed ID: 9559883
[TBL] [Abstract][Full Text] [Related]
11. Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters.
Lin CS; Chow S; Lau A; Tu R; Lue TF
Int J Impot Res; 2002 Feb; 14(1):15-24. PubMed ID: 11896473
[TBL] [Abstract][Full Text] [Related]
12. [Effect of berberine on the mRNA expression of phosphodiesterase type 5 (PDE5) in rat corpus cavernosum].
Tan Y; Tang Q; Hu B; Xiang J
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):890-3. PubMed ID: 15638014
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
White JB; Thompson WJ; Pittler SJ
Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
[TBL] [Abstract][Full Text] [Related]
15. Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects.
Foresta C; Caretta N; Zuccarello D; Poletti A; Biagioli A; Caretti L; Galan A
Eye (Lond); 2008 Jan; 22(1):144-9. PubMed ID: 17585311
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
[TBL] [Abstract][Full Text] [Related]
17. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
van Dinten LC; Pul N; van Nieuwpoort AF; Out CJ; Jager MJ; van den Elsen PJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):24-30. PubMed ID: 15623750
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells.
DiPaola RS; Kuczynski WI; Onodera K; Ratajczak MZ; Hijiya N; Moore J; Gewirtz AM
Cancer Gene Ther; 1997; 4(3):176-82. PubMed ID: 9171936
[TBL] [Abstract][Full Text] [Related]
19. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study.
Oelke M; Hedlund P; Albrecht K; Ellinghaus P; Stief CG; Jonas U; Andersson KE; Uckert S
Urology; 2006 May; 67(5):1111-6. PubMed ID: 16635522
[TBL] [Abstract][Full Text] [Related]
20. Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells.
Zhu B; Vemavarapu L; Thompson WJ; Strada SJ
J Cell Biochem; 2005 Feb; 94(2):336-50. PubMed ID: 15526282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
